Validation of Surrogate Endpoints In Melanoma Therapies and Use In HTA
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1992
https://www.valueinhealthjournal.com/article/S1098-3015(17)32326-4/fulltext
Title :
Validation of Surrogate Endpoints In Melanoma Therapies and Use In HTA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32326-4&doi=10.1016/j.jval.2017.08.1992
First page :
A731
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
1818